The Role of Probiotics as Adjuvant Therapy for Irritable Bowel Syndrome in Children
DOI:
https://doi.org/10.58344/jws.v4i8.1473Keywords:
Irritable Bowel Syndrome, Child, Probiotics, Therapy, ManagementAbstract
Irritable Bowel Syndrome (IBS) is a functional gastrointestinal disorder (GGIF) that is not caused by disease or organ damage. The exact pathophysiological mechanisms underlying IBS are still unknown. The pathogenesis of IBS involves alterations of gastrointestinal motility, post-infection reactivity, visceral hypersensitivity, gut-brain interactions, microbiota dysbiosis, bacterial overgrowth in the small intestine, sensitivity to food, carbohydrate malabsorption, and intestinal inflammation. Evidence of the efficacy of most pharmacological treatments for IBS is still weak, leading to unsatisfactory symptom control or the possibility of adverse reactions in many patients. The method of writing this article is in the form of a narrative review from various sources including google scholar, PubMed, and science direct with the keywords "irritable bowel syndrome" and "child" to summarize the role of probiotics as adjuvant therapy in the management of IBS in children. Probiotics are emerging as a new therapeutic option in gastrointestinal functional disorders (GGIF), along with the recognition of the importance of the gut microbiota in influencing brain-gut interactions, as well as the role of intestinal infections in the genetics of post-infectious gastrointestinal functional disorder (GGIF-PI). Therefore, probiotics have the potential to play a relevant role in the management of GGIF, both through their effects on the gut microbiota and through alterations of brain function and pain perception centrally.
References
Adams, H. L., Basude, D., Kyle, A., Sandmann, S., & Paul, S. P. (2016). Managing irritable bowel syndrome in children. Nursing Standard (Royal College of Nursing (Great Britain): 1987), 31(7). https://doi.org/10.7748/ns.2016.e10439
Adeniyi, O. F., Lesi, O. A., Olatona, F. A., Esezobor, C. I., & Ikobah, J. M. (2017). Irritable bowel syndrome in adolescents in Lagos. Pan African Medical Journal, 28. https://doi.org/10.11604/pamj.2017.28.93.11512
Al-Biltagi, M., El Amrousy, D., El Ashry, H., Maher, S., Mohammed, M. A., & Hasan, S. (2022). Effects of adherence to the Mediterranean diet in children and adolescents with irritable bowel syndrome. World Journal of Clinical Pediatrics, 11(4). https://doi.org/10.5409/wjcp.v11.i4.330
Camilleri, M., Oduyebo, I., & Halawi, H. (2016). Chemical and molecular factors in irritable bowel syndrome: Current knowledge, challenges, and unanswered questions. American Journal of Physiology - Gastrointestinal and Liver Physiology, 311(5). https://doi.org/10.1152/ajpgi.00242.2016
Devanarayana, N. M., & Rajindrajith, S. (2018). Irritable bowel syndrome in children: Current knowledge, challenges and opportunities. World Journal of Gastroenterology, 24(21). https://doi.org/10.3748/wjg.v24.i21.2211
Giannetti, E., Maglione, M., Alessandrella, A., Strisciuglio, C., De Giovanni, D., Campanozzi, A., Miele, E., & Staiano, A. (2017). A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: A multicenter, randomized, double-blind, placebo-controlled, crossover trial. Journal of Clinical Gastroenterology, 51(1), e5–e10. https://doi.org/10.1097/MCG.0000000000000528
Giannetti, E., & Staiano, A. (2016). Probiotics for irritable bowel syndrome: Clinical data in children. Journal of Pediatric Gastroenterology and Nutrition, 63(Suppl 1), S25–S26. https://doi.org/10.1097/MPG.0000000000001220
Hollister, E. B., Oezguen, N., Chumpitazi, B. P., Luna, R. A., Weidler, E. M., Rubio-Gonzales, M., Dahdouli, M., Cope, J. L., Mistretta, T. A., Raza, S., Metcalf, G. A., Muzny, D. M., Gibbs, R. A., Petrosino, J. F., Heitkemper, M., Savidge, T. C., Shulman, R. J., & Versalovic, J. (2019). Leveraging human microbiome features to diagnose and stratify children with irritable bowel syndrome. Journal of Molecular Diagnostics, 21(3). https://doi.org/10.1016/j.jmoldx.2019.01.006
Hyams, J. S., Di Lorenzo, C., Saps, M., Shulman, R. J., Staiano, A., & van Tilburg, M. (2016). Functional disorders: Children and adolescents. Gastroenterology, 150(6), 1456–1468.e2.
Kesuma, Y., Sekartini, R., Timan, I. S., Kurniawan, A., Bardosono, S., Firmansyah, A., & Vandenplas, Y. (2021). Irritable bowel syndrome in Indonesian adolescents. Jornal de Pediatria, 97(2), 197–203. https://doi.org/10.1016/j.jped.2020.02.001
Kianifar, H., Jafari, S. A., Kiani, M., Ahanchian, H., Ghasemi, S. V., Grover, Z., Mahmoodi, L. Z., Bagherian, R., & Khalesi, M. (2015). Probiotic for irritable bowel syndrome in pediatric patients: A randomized controlled clinical trial. Electronic Physician, 7(5), 1255–1260. https://doi.org/10.14661/1255
Masaoka, T., & Kanai, T. (2019). Current knowledge of irritable bowel syndrome-treatment. Journal of Japanese Society of Gastroenterology, 116(7). https://doi.org/10.11405/nisshoshi.116.570
Pesce, M., Puoti, M. G., Rybak, A., Andreozzi, M., Bruzzese, E., Sarnelli, G., & Borrelli, O. (2022). Pharmacological interventions for pediatric irritable bowel syndrome. Expert Opinion on Pharmacotherapy, 23(1). https://doi.org/10.1080/14656566.2021.1976753
Piriyakitphaiboon, V., Sirinam, S., Noipayak, P., Sirivichayakul, C., Pornrattanarungsri, S., & Limkittikul, K. (2022). Risk factors for recurrent abdominal pain in children with nonorganic acute abdominal pain. Pediatric Gastroenterology, Hepatology and Nutrition, 25(2). https://doi.org/10.5223/pghn.2022.25.2.129
Pop, D., Man, S. C., & Farc?u, D. (2025). Anxiety and depression in children with irritable bowel syndrome—A narrative review. Diagnostics, 15(4), 433. https://doi.org/10.3390/diagnostics15040433
Rexwinkel, R., Vlieger, A. M., Saps, M., Tabbers, M. M., & Benninga, M. A. (2022). A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified. European Journal of Pediatrics, 181(7), 2603–2617. https://doi.org/10.1007/s00431-022-04459-y
Sandhu, B. K., & Paul, S. P. (2014). Irritable bowel syndrome in children: Pathogenesis, diagnosis and evidence-based treatment. World Journal of Gastroenterology, 20(20), 6013–6023. https://doi.org/10.3748/wjg.v20.i20.6013
Schmulson, M. J., & Drossman, D. A. (2017). What is new in Rome IV. Journal of Neurogastroenterology and Motility, 23(2), 151–163. https://doi.org/10.5056/jnm16214
Tang, H. Y., Jiang, A. J., Wang, X. Y., Wang, H., Guan, Y. Y., Li, F., & Shen, G. M. (2021). Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: A narrative review. Annals of Translational Medicine, 9(14), 1187. https://doi.org/10.21037/atm-21-2779
Yang, R., Jiang, J., Ouyang, J., Zhao, Y., & Xi, B. (2024). Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis. Clinical Nutrition ESPEN, 60, 362–372. https://doi.org/10.1016/j.clnesp.2024.02.025
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ananda Rizky
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
